Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third-dose MenABCWY booster study in healthy adolescents previously vaccinated in V102_16
2015-001030-16Phase 2
- Sponsor
- Novartis
- Start
- Apr 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Meningococcal ABCYW vaccine in meningococcal disease, sponsored by Novartis.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2015-001030-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001030-16.